Sanket Pharmaceuticals Pvt Ltd

Sanket Pharmaceuticals Pvt Ltd - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24239MH1983PTC031464 Incorporated 01 December 1983 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹2.71 Cr
▼ 8% YoY
Net profit · FY 2025
₹4.56 Lakh
Net margin 1.7%
EBITDA · FY 2025
₹11.19 Lakh
EBITDA margin 4.1%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹15.32 Lakh
Issued & subscribed
Open charges
₹19 Lakh
Satisfied ₹50 Lakh
Company age
43 yrs
Est. 1983
Directors on board
3
As per MCA filings

About Sanket Pharmaceuticals Pvt Ltd

Data last updated:

Sanket Pharmaceuticals Pvt Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 December 1983 and has been in existence for over 43 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1983PTC031464. Its GSTIN is 27AAECS1509B1ZU (Maharashtra).

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹15.32 Lakh. It is led by directors including Arti Rakesh Jain and Rakesh Parasmal Jain.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 196 A Tara Houseshop No 3 Dr Viegas Street Cavel X Lane – 8, Mumbai, Maharashtra, India – 400002.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.71 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹4.56 Lakh (net margin 1.7%) and EBITDA of ₹11.19 Lakh (EBITDA margin 4.1%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 8% over five years.

As per MCA filings, the company has open charges of ₹19 Lakh and satisfied charges of ₹50 Lakh on record. Court records list 8 cases involving the company, including 3 filed by the company and 5 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sanketpharma.net.

Company details

CIN U24239MH1983PTC031464
Registration Number 031464
Incorporation Date 01 December 1983
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Sanket Pharmaceuticals Pvt Ltd's registered office is in Mumbai, Maharashtra. Its website is sanketpharma.net. Its e-mail address is in the company report.

  • Email
  • Registered Address
    196 A Tara Houseshop No 3 Dr Viegas Street Cavel X Lane – 8, Mumbai, Maharashtra, India – 400002
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Sanket Pharmaceuticals Pvt Ltd, buy the company report.

Comprehensive company report
Sanket Pharmaceuticals Pvt Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Sanket Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Sanket Pharmaceuticals Pvt Ltd, buy the company report.

Financials of Sanket Pharmaceuticals Pvt Ltd

FY 2025 filings available

Sanket Pharmaceuticals Pvt Ltd reported revenue of ₹2.71 Cr (down 8% YoY) for FY 2025.

Revenue · FY 2025
₹2.71 Cr ▼ 8%
Net profit · FY 2025
₹4.56 Lakh margin 1.7%
EBITDA · FY 2025
₹11.19 Lakh margin 4.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▼ 8%
5 years · compounded
▼ 8%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▼ 3%
5 years · compounded
▼ 8%

Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 8% fall in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹11.19 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹4.56 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin4.1%
Net Profit Margin1.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sanket Pharmaceuticals Pvt Ltd, buy the company report.

Board of directors of Sanket Pharmaceuticals Pvt Ltd

Sanket Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Arti Rakesh JainDirector05 Feb 20215 Years 8 MonthsCurrent
Rakesh Parasmal JainDirector26 Feb 201313 Years 7 MonthsCurrent
Dinesh Parasmal JainDirector18 Dec 199530 Years 10 MonthsCurrent

Peer comparison

Sanket Pharmaceuticals Pvt Ltd is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Tetramed Biotek Private Limited₹2.73 Cr (FY 2022)4.0%Pune, Maharashtra, India
Sanket Pharmaceuticals Pvt Ltdthis company₹2.71 Cr (FY 2025)₹4.56 Lakh1.7%-8.0%Mumbai, Maharashtra, India
Umar Medicare Private Limited₹2.71 Cr (FY 2022)269.0%Delhi, India
Roris Pharmaceuticals Private Limited₹2.71 Cr (FY 2025)-8.0%Jaipur, Rajasthan, India
Unimac Pharmaceutical Private Limited₹2.71 Cr (FY 2025)28.0%New Delhi, Delhi, India
Medtabs Pharma Private Limited₹2.71 Cr (FY 2024)40.0%Satara, Maharashtra, India

To see the full peer comparison of Sanket Pharmaceuticals Pvt Ltd, buy the company report.

Auditor

Sanket Pharmaceuticals Pvt Ltd is audited by RAMAN JAIN & ASSOCIATES for the financial year 2021.

Auditor firmFinancial yearFirm registration number
RAMAN JAIN & ASSOCIATESFY 2021129607W

Shareholding

The shareholding of Sanket Pharmaceuticals Pvt Ltd is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sanket Pharmaceuticals Pvt Ltd, buy the company report.

Charges & borrowings

Open charges
₹19 Lakh
Satisfied charges
₹50 Lakh
Breakdown by lending institutions
Sttae Bank of India₹0.19 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Mar 199590243235Sttae Bank of India₹3 LakhOpen
12 Jan 198890242960Sttae Bank of India₹16 LakhOpen
30 Mar 200190243514Corporation Bank₹50 LakhSatisfied

To see the full charge records of Sanket Pharmaceuticals Pvt Ltd, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sanket Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Sanket Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAECS1509B1ZUMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Sanket Pharmaceuticals Pvt Ltd, buy the company report.

Recent activity

Sanket Pharmaceuticals Pvt Ltd has 7 board changes on record since 1995: 4 appointments and 3 cessations. The latest: Palak Dinesh Jain ceased to be Director on 03 May 2025.

Charges
A charge registered on 30 Mar 2001 via Charge ID 90243514 with Corporation Bank was fully satisfied on 17 Nov 2025.
AGM
Sanket Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Palak Dinesh Jain ceased to be Director.
Filing
Sanket Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Palak Dinesh Jain was appointed as Director.
Appointed
Arti Rakesh Jain was appointed as Director.
Ceased
Mishrimal Valchand Jain ceased to be Director.
Ceased
Rakesh Parasmal Jain ceased to be Additional Director.
Appointed
Rakesh Parasmal Jain was appointed as Director.
Charges
A charge with Corporation Bank amounted to Rs. 50.00 Lakh with Charge ID 90243514 was registered on 30 Mar 2001.
Charges
A charge with Corporation Bank of Rs. 50.00 Lakh registered on 30 Mar 2001 with Charge ID 90243514 was modified on 30 Mar 2001.
Appointed
Dinesh Parasmal Jain was appointed as Director.

4 earlier events are in the company report.

Frequently asked questions

Sanket Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 December 1983 (43+ years old) and is registered under CIN U24239MH1983PTC031464.

Sanket Pharmaceuticals has 3 current directors:

The latest financial statements of Sanket Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Sanket Pharmaceuticals is 27AAECS1509B1ZU, registered in Maharashtra.

The CIN (Corporate Identification Number) of Sanket Pharmaceuticals is U24239MH1983PTC031464. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sanket Pharmaceuticals has 8 court cases on record: 3 filed by the company and 5 filed against it. Most are in the district courts.

Sanket Pharmaceuticals was incorporated on 01 December 1983, making it 43+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Sanket Pharmaceuticals by revenue are Tetramed Biotek Private Limited, Umar Medicare Private Limited, Roris Pharmaceuticals Private Limited, Unimac Pharmaceutical Private Limited, Medtabs Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Palak Dinesh Jain ceased to be Director on 03 May 2025. Palak Dinesh Jain was appointed as Director on 01 Oct 2021. Arti Rakesh Jain was appointed as Director on 05 Feb 2021. Sanket Pharmaceuticals has 7 board changes on record in total.

Sanket Pharmaceuticals can be reached through the website sanketpharma.net. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Sanket Pharmaceuticals is at 196 A Tara Houseshop No 3 Dr Viegas Street Cavel X Lane – 8, Mumbai, Maharashtra, India – 400002.